Triumeq
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
49702-231 -
Package NDC
49702-231-13 -
Application number
NDA205551 -
SPL ID
4018a8c7-db0d-481e-b50a-a469ba32ec4b -
SPL set ID
2997739a-aa91-42aa-a206-a70e2db7b84f -
UNII
J220T4J9Q2 -
UNII
1Q1V9V5WYQ -
UNII
2T8Q726O95 -
RxCUI
1546888 -
RxCUI
1546894 -
RxCUI
2598348 -
RxCUI
2598352
What the source publishes
- Labeler
- ViiV Healthcare Company
- Active ingredients
- abacavir sulfate, dolutegravir sodium, lamivudine
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- Triumeq
- abacavir sulfate, dolutegravir sodium, lamivudine
- ABACAVIR SULFATE
- DOLUTEGRAVIR SODIUM
- LAMIVUDINE
Complete source data
{
"name": "Triumeq",
"splId": "4018a8c7-db0d-481e-b50a-a469ba32ec4b",
"labels": [
{
"setId": "2997739a-aa91-42aa-a206-a70e2db7b84f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2997739a-aa91-42aa-a206-a70e2db7b84f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2997739a-aa91-42aa-a206-a70e2db7b84f"
}
],
"routes": [
"ORAL"
],
"labeler": "ViiV Healthcare Company",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)",
"package_ndc": "49702-231-13",
"identifierStatus": "well-formed",
"marketing_start_date": "20140822"
}
],
"productId": "49702-231_4018a8c7-db0d-481e-b50a-a469ba32ec4b",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "49702-231",
"deaSchedule": null,
"genericName": "abacavir sulfate, dolutegravir sodium, lamivudine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ABACAVIR SULFATE",
"strength": "600 mg/1"
},
{
"name": "DOLUTEGRAVIR SODIUM",
"strength": "50 mg/1"
},
{
"name": "LAMIVUDINE",
"strength": "300 mg/1"
}
],
"applicationNumber": "NDA205551",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140822",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175656",
"N0000175462",
"N0000009947"
],
"upc": [
"0349702231139"
],
"unii": [
"J220T4J9Q2",
"1Q1V9V5WYQ",
"2T8Q726O95"
],
"rxcui": [
"1546888",
"1546894",
"2598348",
"2598352"
],
"spl_set_id": [
"2997739a-aa91-42aa-a206-a70e2db7b84f"
],
"pharm_class_epc": [
"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleoside Reverse Transcriptase Inhibitors [MoA]"
],
"manufacturer_name": [
"ViiV Healthcare Company"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:49702-231_4018a8c7-db0d-481e-b50a-a469ba32ec4b"